An updated review of glucocorticoid-related adverse events in patients with rheumatoid arthritis-Reference-Cited by-同舟云学术

An updated review of glucocorticoid-related adverse events in patients with rheumatoid arthritis

Published:2019-05-14 Issue:7 Volume:18 Page:581-590
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Luís Mariana¹,Freitas João¹,Costa Flávio¹,Buttgereit Frank²,Boers Maarten³,JAP Da Silva¹⁴⁵,Santiago Tânia¹⁴^ORCID

Affiliation:

1. Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal

2. Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin, Germany

3. Department of Epidemiology and Biostatistics, Amsterdam Rheumatology and Immunology Center, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands

4. Faculty of Medicine, University of Coimbra, Coimbra, Portugal

5. Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2019.1615052

Reference50 articles.

1. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: A two-year randomized trial

2. Low-Dose Prednisone Inclusion in a Methotrexate-Based, Tight Control Strategy for Early Rheumatoid Arthritis

3. Low-dose oral prednisone improves clinical and ultrasonographic remission rates in early rheumatoid arthritis. Results of a 12 month open-label randomized study.

4. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the therapeutic potential of regulatory T cell in rheumatoid arthritis: Insights into subsets, markers, and signaling pathways;Biomedicine & Pharmacotherapy;2024-05

2. Comprehensive insights into rheumatoid arthritis: Pathophysiology, current therapies and herbal alternatives for effective disease management;Phytotherapy Research;2024-03-24

3. A preliminary survey of rheumatologists on the management of late-onset rheumatoid arthritis in Japan;Internal Medicine;2024

4. Glucocorticoid-loaded pH/ROS dual-responsive nanoparticles alleviate joint destruction by downregulating the NF-κB signaling pathway;Acta Biomaterialia;2023-07

5. Arterial Stiffness as a Surrogate Marker of Cardiovascular Disease and Atherosclerosis in Patients with Arthritides and Connective Tissue Diseases: A Literature Review;Diagnostics;2023-05-26